艾伯維公司 ABBV 深 滬
等待開盤 10-31 09:30:00 美东时间
228.20
+3.060
+1.36%
華盛通- 最 高229.65
- 今 開227.05
- 成交量 501.98万股
- 最 低 226.41
- 昨 收 225.14
- 總市值 4032.29亿
- 52周最高 243.17
- 市盈率 靜 95.47
- 換手率 0.00%
- 52周最低 157.25
- 委 比 -90.48%
- 總股本 17.67亿
- 歷史最高 243.17
- 量 比 1.18
- 振 幅 1.44%
- 歷史最低 -16.88
- 每 手 1
- 風險率 18.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多AbbVie in charts: Revenues from Humira -55%, Skyrizi +47%, Rinvoq +35% Y/Y
Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha More on AbbVie AbbVie: Deep Discount Before Earnings AbbVie: "Strong Buy" On Rinvoq Expansions And Immunology Pipeline Addition AbbVie: Wins...
28分钟前
AbbVie Raises FY2025 Adj EPS Guidance from $10.38-$10.58 to $10.61-$10.65 vs $10.53 Est
AbbVie (NYSE:ABBV) raises FY2025 Adj EPS guidance from $10.38-$10.58 to $10.61-$10.65 vs $10.53 analyst estimate..
29分钟前
AbbVie Q3 Adj. EPS $1.86 Beats $1.79 Estimate, Sales $15.776B Beat $15.590B Estimate
AbbVie (NYSE:ABBV) reported quarterly earnings of $1.86 per share which beat the analyst consensus estimate of $1.79 by 4.09 percent. This is a 38 percent decrease over earnings of $3.00 per share from the same period
31分钟前
AbbVie raises dividend by 5.5%
AbbVie (ABBV) declared $1.73/share quarterly dividend, 5.5% increase from prior dividend of $1.64. Forward yield 3.03% Payable Feb. 17; for shareholders of record Jan. 16; ex-div Jan. 16. See ABBV Div...
34分钟前
Earnings Scheduled For October 31, 2025
Companies Reporting Before The Bell • T. Rowe Price Group (NASDAQ:TROW) is esti...
今天 19:11
华盛早报 | 美参议院通过决议：终止特朗普“全球征税”！史上最大IPO？OpenAI预计2026年筹备上市；亚马逊盘后狂飙14%
美参议院通过决议：终止特朗普“全球征税”！史上最大IPO？OpenAI预计2026年筹备上市；亚马逊盘后狂飙14%，Meta暴跌11.33%；超24万人爆仓！加密货币全线受挫>>
今天 08:26
AbbVie's Earnings Outlook
AbbVie (NYSE:ABBV) is preparing to release its quarterly earnings on Friday, 20...
10-30 22:02
McKesson declares $0.82 dividend
McKesson (MCK) declares $0.82/share quarterly dividend, in line with previous. Forward yield 0.41% Payable Jan. 2; for shareholders of record Dec. 1; ex-div Dec. 1. See MCK Dividend Scorecard, Yield C...
10-30 20:07
Thermo Fisher to buy Clario for ~$8.9B plus earnouts
Thermo Fisher Scientific (NYSE:TMO) has confirmed a deal to acquire clinical trial data management firm Clario Holdings from a shareholder group led by Astorg and Nordic Capital, Novo Holding, and Cin...
10-29 18:16
致敬时代丨全球近2亿人受困！针对失明的主要原因，创新疗法助他们“点亮”失去的世界
（来源：药明康德） 转自：药明康德 编者按：2025年，药明康德迎来创立25周年的重要里程碑。值此契机，我们向所有与我们共同书写产业变革篇章的科学家、医药人和投...
10-29 07:32
